EGFR and neoplasm: Reports from other authors have shown that lapatinib, a dual inhibitor of EGFR and HER2, combined with the mTOR inhibitor rapamycin induced significant in vitro growth inhibition of TNBC cell lines and synergistically reduced tumour growth in TNBC cell-derived xenograft models23.